Neal Shore, MD, FACS

Neal Shore, MD, FACS

Articles by Neal Shore, MD, FACS

Overcoming the BCG Shortage With TARA-002 for High-Grade NMIBC

Neal Shore, MD, FACSNon-Muscle Invasive Urothelial Carcinoma | January 6, 2025

Dr. Neal Shore discusses how the investigational treatment TARA-002 can aid patients during the ongoing BCG shortage.

The ABLE-32 Study: Nadofaragene Firadenovec for Intermediate-Risk NMIBC

Neal Shore, MD, FACSNon-Muscle Invasive Urothelial Carcinoma | January 6, 2025

Dr. Neal Shore reviews the history of nadofaragene firadenovec in high-risk disease, and the anticipated outcomes of ABLE-32.

Advancing Localized Prostate Cancer Treatment: Effects of Apalutamide, ADT

Neal Shore, MD, FACSLocalized | June 13, 2024

Dr. Shore discusses treatment-related adverse events associated with apalutamide and ADT.

Apalutamide, ADT Improve Outcomes in High-Risk Prostate Cancer Post-Surgery

Neal Shore, MD, FACSLocalized | June 13, 2024

Dr. Shore discusses the effects of apalutamide plus ADT in patients with prostate cancer.